trending Market Intelligence /marketintelligence/en/news-insights/trending/twwbvo2twr8patfldcapng2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

AFT, Angelini partner to license cold, flu product in 16 additional countries

South Korean Multichannel Industry To Survive With Right Strategies

South Korean Telcos Drive Next Wave Of Growth Through Home IoT Opportunities

Mining Exploration Insights: Financing Falls To 8-Month Low In October

Taking Advantage of Issuance Trends in 2020


AFT, Angelini partner to license cold, flu product in 16 additional countries

AFT Pharmaceuticals Ltd. entered an alliance agreement with Angelini Acraf SpA to license AFT's Maxiclear patented combination cold-and-flu product line in an additional 16 countries.

The added countries include Italy, San Marino, Vatican City, Spain, Portugal, Greece, Bulgaria, Croatia, Czech Republic, Slovakia, Austria, Romania, Poland, Hungary, Turkey and Russia.